PharmacyCodes



Cilostazolum [Inn-Latin] en es it fr

Cilostazolum [Inn-Latin] Brand names, Cilostazolum [Inn-Latin] Analogs

Cilostazolum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Cilostazolum [Inn-Latin] Chemical_Formula

C20H27N5O2

Cilostazolum [Inn-Latin] RX_link

http://www.rxlist.com/cgi/generic/cilostaz.htm

Cilostazolum [Inn-Latin] fda sheet

http://www.fda.gov/cder/foi/label/1999/cilo_label.htm

Cilostazolum [Inn-Latin] msds (material safety sheet)

Cilostazolum_[Inn-Latin] MSDS

Cilostazolum [Inn-Latin] Synthesis Reference

No information avaliable

Cilostazolum [Inn-Latin] Molecular Weight

369.461 g/mol

Cilostazolum [Inn-Latin] Melting Point

160 oC

Cilostazolum [Inn-Latin] H2O Solubility

No information avaliable

Cilostazolum [Inn-Latin] State

Solid

Cilostazolum [Inn-Latin] LogP

2.686

Cilostazolum [Inn-Latin] Dosage Forms

No information avaliable

Cilostazolum [Inn-Latin] Indication

For the reduction of symptoms of intermittent claudication (pain in the legs that occurs with walking and disappears with rest)

Cilostazolum [Inn-Latin] Pharmacology

Cilostazol is a quinolinone derivative indicated for the reduction of symptoms of intermittent claudication, as indicated by an increased walking distance. Intermittent claudication is pain in the legs that occurs with walking and disappears with rest. The pain occurs due to reduced blood flow to the legs.

Cilostazolum [Inn-Latin] Absorption

No information avaliable

Cilostazolum [Inn-Latin] side effects and Toxicity

No information avaliable

Cilostazolum [Inn-Latin] Patient Information

No information avaliable

Cilostazolum [Inn-Latin] Organisms Affected

Humans and other mammals